Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Revenue: 2011-2024

Historic Revenue for Iovance Biotherapeutics (IOVA) over the last 5 years, with Dec 2024 value amounting to $164.1 million.

  • Iovance Biotherapeutics' Revenue rose 15.20% to $67.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.4 million, marking a year-over-year increase of 175.62%. This contributed to the annual value of $164.1 million for FY2024, which is 13698.99% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Revenue of $164.1 million as of FY2024, which was up 13,698.99% from $1.2 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Revenue registered a high of $164.1 million during FY2024, and its lowest value of $1.2 million during FY2023.
  • Its 2-year average for Revenue is $82.6 million, with a median of $82.6 million in 2023.
  • Data for Iovance Biotherapeutics' Revenue shows a peak YoY surged of 13,698.99% (in 2024) over the last 5 years.
  • Over the past 2 years, Iovance Biotherapeutics' Revenue (Yearly) stood at $1.2 million in 2023, then skyrocketed by 13,698.99% to $164.1 million in 2024.